AUTHOR

Sanket Koul

All stories by Sanket Koul

What's Driving Surge in Breast Cancer?
Rediff.com1 Nov 2024

Late-stage diagnosis is a major issue, with over 75 per cent of cases being detected at...

Now, Karnataka Wants To Scrap NEET
Rediff.com26 Jul 2024

Karnataka has the highest number of medical seats in the country at 11,745, of which...

How To Fix Ayushman Bharat: Experts To FM
Rediff.com28 Jun 2024

'Patients under the scheme may ultimately have to go to private hospitals.'

NEET-PG Delay May Push Doctors Abroad
Rediff.com24 Jun 2024

'The NEET-PG is the only exam for admission to MD, MS and PG Diploma courses.' 'Many...

52% Of Urban Indians Utilise Ayush
Rediff.com18 Jun 2024

Ayush refers to the six Indian systems of medicines, namely Ayurveda, Yoga and...

Expanding Ayushman Bharat On Cards
Rediff.com15 Jun 2024

The move to expand the health insurance scheme's coverage comes at a time when several...

Modi 3.0's Plans For Ayushman Bharat
Rediff.com12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat...

'Fortis plans to add 700 beds in FY25'
Rediff.com12 Jun 2024

'Our priority remains brownfield expansion, and in the next few years, we plan to...

AyushMin gets rap for underuse of funds despite rising allocation
Rediff.com27 Feb 2024

Given the gap between budgetary allocation and use, a parliamentary standing committee...

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles
Rediff.com20 Nov 2023

Pharmaceuticals major Mankind Pharma reported a 21 per cent year-on-year (Y-o-Y)...

IKS Health, backed by Jhunjhunwala family, buys US tech firm for Rs 1,600 cr
Rediff.com1 Nov 2023

AQuity Solutions is a leading tech-enabled clinical documentation, medical coding and...

Israel conflict unlikely to impact trade of pharma firms
Rediff.com12 Oct 2023

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite...